Palvella unwraps Phase 2 data for rapamycin gel in rare skin disease
Palvella unwraps Phase 2 data for rapamycin gel in rare skin disease
Palvella unwraps Phase 2 data for rapamycin gel in rare skin disease
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.